Clinical Chemistry
Main Filters
Clinical Chemistry
| GenePoc Inc | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 130840 | 0 | - | ||
| 132331 | 0 | - | ||
| 133499 | 0 | - | ||
| 133674 | 0 | - | ||
| Meridian Bioscience Canada Inc | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 410200 | 0 | - | ||
| 410400 | 0 | - | ||
| 410500 | 0 | - | ||
| 610208 | 0 | - | ||
| 610210 | 0 | - | ||
| SEKISUI DIAGNOSTICS, LLC | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 082B | 0 | - | ||
| 140-20 | 0 | - | ||
| 140-24 | 0 | - | ||
| 200-05 | 0 | - | ||
| 200-45 | 0 | - | ||
| 243-10 | 0 | - | ||
| 247-30 | 0 | - | ||
| 284-10 | 0 | - | ||
| 284-30 | 0 | - | ||
| 288-36 | 0 | - | ||
| 288-80 | 0 | - | ||
| 293-10 | 0 | - | ||
| 295-30 | 0 | - | ||
| 299-17 | 0 | - | ||
| 299-30 | 0 | - | ||
| 299-50 | 0 | - | ||
| 299-55 | 0 | - | ||
| 299-80 | 0 | - | ||
| 318-30 | 0 | - | ||
| 319-30 | 0 | - | ||
| 328-30 | 0 | - | ||
| 80-5383-00 | 0 | - | ||
| 80-5451-00 | 0 | - | ||
| SK140-10 | 0 | - | ||
| SK157-20 | 0 | - | ||
| SK200-10 | 0 | - | ||
| SK284-20 | 0 | - | ||
| SK299-10 | 0 | - | ||
| SK318-20 | 0 | - | ||
| SK319-20 | 0 | - | ||
| SK328-20 | 0 | - | ||
| Spartan Bioscience Inc | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 01003214 | 0 | - | ||
| 01003359 | 0 | - | ||
| 01003374, 01003372, and 01003373 | 0 | - | ||
| 01003438 | 0 | - | ||
| 01004777 | 0 | - | ||
| 01004872-ABC | 0 | - | ||
| 01004880-ABC (10) | 0 | - | ||
| 01004880-ABC (20) | 0 | - | ||
| 01004985 | 0 | - | ||
| 01004985 | 0 | - | ||
23,619 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Spartan RX CYP2C19 System
Spartan Bioscience Inc
A box of 20 SNP CYP2C19 External Control Kits.
0
-
Spartan RX CYP2C19 System
Spartan Bioscience Inc
A box of 10 CYP2C19 External Control Kits.
0
-
Spartan RX CYP2C19 System
Spartan Bioscience Inc
A box of 20 CYP2C19 Sample Collection Kits.
0
-
Spartan RX CYP2C19 System
Spartan Bioscience Inc
This is Box 2 of 3 for the Spartan RX CYP2C19 Platform. It contains the Spartan RX Netbook (01003214) and the Spartan RX Printer (01003438).
0
-
Spartan RX CYP2C19 System
Spartan Bioscience Inc
This is Box 1 of 3 of the Spartan RX CYP2C19 Platform. It contains the Spartan RX Analyzer (01004777) and the Spartan RX Barcode Scanner (01003359).
0
-
Spartan RX CYP2C19 System
Spartan Bioscience Inc
The Spartan RX Sample Transport System supplied with the Spartan RX CYP2C19 System. It includes: Carrying bag (01003374), Cold block (01003372), and Insulated box (01003373).
0
-
Spartan RX CYP2C19 System
Spartan Bioscience Inc
Barcode Scanner supplied with the Spartan RX CYP2C19 System.
0
-
Spartan RX CYP2C19 System
Spartan Bioscience Inc
Printer supplied with the Spartan RX CYP2C19 System
0
-
Spartan RX CYP2C19 System
Spartan Bioscience Inc
Netbook supplied with the Spartan RX CYP2C19 System.
0
-
Revogene® Strep A
Meridian Bioscience Canada Inc
The Revogene® Strep A assay, performed on the Revogene® instrument, is an automated, qualitative in vitro diagnostic test that utilizes real-time polymerase chain reaction (PCR) for the direct detection of Streptococcus pyogenes (Group A B-hemolytic Streptococcus) nucleic acids from throat swab specimens obtained from patients with signs and symptoms of pharyngitis. The Revogene Strep A assay is intended for use as an aid in the diagnosis of Group A Streptococcus infection.
0
-
Revogene® Carba C
Meridian Bioscience Canada Inc
The Revogene® Carba C assay, performed on the Revogene® instrument, is a qualitative in vitro diagnostic test designed for the detection and differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48-like, and blaIMP gene sequences associated with carbapenem-non-susceptible pure colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa, when grown on blood agar or MacConkey agar. The test utilizes automated real-time Polymerase Chain Reaction (PCR).The Revogene Carba C assay should be used in conjunction with other laboratory tests including phenotypic antimicrobial susceptibility testing. A negative Revogene Carba C assay result does not preclude the presence of other resistance mechanisms.The Revogene Carba C assay is intended as an aid for infection control in the detection of carbapenem-non-susceptible bacteria that colonize patients in healthcare settings. The identification of a blaIMP, blaNDM or blaVIM metallo-B-lactamase gene (i.e., the genes that encode the IMP, NDM and VIM metallo-B-lactamases, respectively) may be used as an aid to clinicians in determining appropriate therapeutic strategies for patients with known or suspected carbapenem non-susceptible infections.
0
-
MOCK PIE
Meridian Bioscience Canada Inc
The MOCK PIE is a re-usable PIE intended for use in conjunction with the Revogene® instrument and Revogene® assays. The MOCK PIE simulates the presence of an assay PIE for thermal and rotational balance when the number of assay PIEs is lower than eight in a run.
0
-
Revogene® GBS LB
Meridian Bioscience Canada Inc
The Revogene® GBS LB assay performed on the Revogene instrument is a qualitative in vitro diagnostic test designed to detect Group B Streptococcus (GBS) DNA from 18-24 hour LIM broth enrichments of vaginal/rectal specimen swabs obtained from pregnant women. The Revogene GBS LB assay utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect a cfb gene sequence specific to the Streptococcus agalactiae genome.The Revogene GBS LB assay is indicated for the identification of antepartum GBS colonization and does not provide susceptibility results. It is not intended to diagnose or monitor treatment of GBS infection. Culture isolates are needed for performing susceptibility testing as recommended for penicillin-allergic women.
0
-
Revogene®
Meridian Bioscience Canada Inc
The Revogene® instrument is intended for in vitro diagnostic (IVD) use in performing nucleic acid testing of specific IVD assays in clinical laboratories. The Revogene is capable of automated lysis and dilution of samples originating from various clinical specimen types. The Revogene performs automated amplification and detection of target nucleic acid sequences by fluorescence-based real time PCR.
0
-
GenePOC™ Strep A
GenePoc Inc
The GenePOC Strep A assay, performed on the revogene instrument, is an automated, qualitative in vitro diagnostic test that utilizes real-time polymerase chain reaction (PCR) for the direct detection of Streptococcus pyogenes (Group A B-hemolytic Streptococcus) nucleic acids from throat swab specimens obtained from patients with signs and symptoms of pharyngitis. The GenePOC Strep A assay is intended for use as an aid in the diagnosis of Group A Streptococcus infection.
0
-
GenePOC™ Carba
GenePoc Inc
The GenePOC™ Carba assay, performed on the revogene™ instrument, is a qualitative in vitro diagnostic test designed for the detection and differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48-like, and blaIMP gene sequences associated with carbapenem-non-susceptible pure colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa, when grown on blood agar or MacConkey agar. The test utilizes automated real-time Polymerase Chain Reaction (PCR).The GenePOC Carba assay should be used in conjunction with other laboratory tests including phenotypic antimicrobial susceptibility testing. A negative GenePOC Carba assay result does not preclude the presence of other resistance mechanisms.The GenePOC Carba assay is intended as an aid for infection control in the detection of carbapenem-non-susceptible bacteria that colonize patients in healthcare settings. The identification of a blaIMP, blaNDM or blaVIM metallo-B-lactamase gene (i.e., the genes that encode the IMP, NDM and VIM metallo-B-lactamases, respectively) may be used as an aid to clinicians in determining appropriate therapeutic strategies for patients with known or suspected carbapenem non-susceptible infections.
0
-
MOCK PIE
GenePoc Inc
The MOCK PIE is a re-usable PIE intended for use in conjunction with the revogene™ instrument and GenePOC assays. The MOCK PIE simulates the presence of an assay PIE for thermal and rotational balance when the number of assay PIEs is lower then eight in a run.
0
-
revogene™
GenePoc Inc
The revogene™ instrument is intended for in vitro diagnostic (IVD) use in performing nucleic acid testing of specific IVD assays in clinical laboratories. The revogene is capable of automated lysis and dilution of samples originating from various clinical specimen types. revogene performs automated amplification and detection of target nucleic acid sequences by fluorescence-based real-time PCR.
